Live Breaking News & Updates on நியோ குமா முயற்சிகள்

Stay updated with breaking news from நியோ குமா முயற்சிகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Neo Kuma psychedelics VC fund interview with Burtenshaw


Neo Kuma Ventures is a new venture fund in London that s just for investing in psychedelics.
Psychedelics are mind-altering substances, like the psilocybin found in magic mushrooms. 
Early research suggests that psychedelics could be used to treat health conditions, like mental illnesses resistant to conventional treatments. 
Psychedelics is an emerging industry worldwide, separate to cannabis. Canada, the US and Europe are frontrunners.
Neo Kuma s 35-year-old co-founder shared her strategy for an emerging and risky field.
Clara Burtenshaw had a personal interest in psychedelics that s now become her job. The 35-year-old lawyer has just started a venture fund in the UK, devoted to investing in psychedelics. ....

United Kingdom , City Of , Neo Kuma , David Nutt , Beckley Psytech , Vikram Patel , Sean Mclintock , Clara Burtenshaw , Tim Ferris , Edmondj Safra , Amanda Feilding , Nick David , Life Sciences , Lancet Commission , Beckley Foundation , Neo Kuma Ventures , Silicon Valley , Leafy Tunnel , Neuropsychopharmacology Unit , Brain Sciences , Imperial College London , Business Insider , United Kingdom Based , Bright Minds , Bright Mind , ஒன்றுபட்டது கிஂக்டம் ,

Healthcare takes on psychedelics | Laboratory News


17 Dec 2020
Share:
More and more revolutionary mind-altering medicines and treatments based on active ingredients previously spurned as street drugs, such as ketamine and psilocybin (magic mushrooms), are gaining acceptance with regulators. Clinical trials show psychedelics have huge potential to help people with treatment resistant mental illnesses including depression, addiction, anxiety and inflammation. So, with the launch of its first investment fund, will the psychedelic healthcare sector run at the heels of the medicinal cannabis industry and enable Europe to become the new hub of a burgeoning market sector? 
The UK s first investment fund dedicated solely to psychedelic healthcare has launched. ....

United Kingdom , Neo Kuma , Beckley Psytech , Sean Mclintock , World Health Organization , Drug Administration , Centre For Mental Health , Dr David Nutt At Imperial College London , Life Sciences , Lancet Commission , Neo Kuma Ventures , London Based Venture Capital , Kuma Ventures , Bright Minds , Imperial College London , Mental Health , ஒன்றுபட்டது கிஂக்டம் , நியோ குமா , சீன் மக்லிஂடாக் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , மையம் க்கு மன ஆரோக்கியம் , டாக்டர் டேவிட் நட் இல் ஏகாதிபத்தியம் கல்லூரி லண்டன் , வாழ்க்கை அறிவியல் , நியோ குமா முயற்சிகள் , லண்டன் அடிப்படையிலானது துணிகர மூலதனம் , குமா முயற்சிகள் ,